Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.
Saved in:
| Title: | Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential. |
|---|---|
| Authors: | Chakraborty A; AllExcel, Inc, West Haven, Connecticut, United States of America., Diwan A; Nanoviricide Inc, Shelton, Connecticut, United States of America., Chiniga V; AllExcel, Inc, West Haven, Connecticut, United States of America., Arora V; AllExcel, Inc, West Haven, Connecticut, United States of America., Thakur Y; AllExcel, Inc, West Haven, Connecticut, United States of America., Tatake J; AllExcel, Inc, West Haven, Connecticut, United States of America., Pandey R; AllExcel, Inc, West Haven, Connecticut, United States of America., Holkar P; AllExcel, Inc, West Haven, Connecticut, United States of America., Holkar N; AllExcel, Inc, West Haven, Connecticut, United States of America. |
| Source: | PloS one [PLoS One] 2026 Feb 20; Vol. 21 (2), pp. e0324811. Date of Electronic Publication: 2026 Feb 20 (Print Publication: 2026). |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0324811 |
